Tectonic Therapeutic, Inc. 4

CFO Daniel Lochner received an option award for 24,250 shares of Tectonic Therapeutic, Inc. common stock at a $29.92 exercise price.

On September 3, 2026, Tectonic Therapeutic, Inc. Chief Financial Officer Daniel Lochner was granted an employee stock option to purchase 24,250 shares of the company’s common stock at an exercise price of $29.92 per share, expiring on September 2, 2036. The option, which represents a total potential value of approximately $725,000 at the grant price, will vest as to 1/8 of the shares on September 3, 2026, with the remaining shares vesting in 42 equal monthly installments beginning October 3, 2026, contingent on his continued service. Following this grant, Lochner beneficially holds 24,250 derivative securities (options) corresponding to 24,250 shares of common stock; no contemporaneous market purchases or sales of common stock were reported in this filing.

Filing Facts

CIK

1681087

Ticker

TECX

Form

4

Source Type

fda

Accession

0001791187-26-000008

Alert Tier

5